Novo Holdings A/S, 10% Owner at Edgewise Therapeutics, Inc. (EWTX), bought 968,992 shares at $10.32 ($10.0M) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market purchase of $10.0M EWTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.32 | 484,496 | $5.0M | 50.0% |
| 2 | $10.32 | 484,496 | $5.0M | 50.0% |
| Total | $10.32 avg | 968,992 | $10.0M | 100% |
| Filing → |
| IOBT | SELL | 2024-07-26 | $168K | — | Filing → |
| IOBT | SELL | 2024-05-14 | $1.6M | — | Filing → |
| SPRB | SELL | 2024-03-25 | $698K | — | Filing → |